Taiwan

6 Vaccines Approved for Use in Taiwan

Protein Subunit

Medigen

MVC-COV1901

Approved in 4 countries
15 trials in 4 countries
Approval Source: reuters.com
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
Approval Source: taiwannews.com.tw
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Approval Source: cdc.gov.tw
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Protein Subunit

Novavax

Nuvaxovid

Approved in 40 countries
22 trials in 14 countries
Approval Source: taiwannews.com.tw
RNA

Moderna

Spikevax Bivalent Original/Omicron BA.1

Approved in 38 countries
5 trials in 4 countries
Approval Source: taipeitimes.com

7 in Clinical Trials in Taiwan

Protein Subunit

COVAXX

UB-612

7 trials in 2 countries
Protein Subunit

Medigen

MVC-COV1901

Approved in 4 countries
15 trials in 4 countries
RNA

Moderna

Spikevax

Approved in 88 countries
70 trials in 24 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 149 countries
73 trials in 34 countries
Protein Subunit

Adimmune Corporation

AdimrSC-2f

3 trials in 2 countries
Protein Subunit

Medigen

MVC-COV1901(Beta)